The approval of perpetual futures contracts in the US may expose traders to unforeseen tax and regulatory uncertainty, as the products' classification as either swaps or futures remains ambiguous, CME Group Chairman and CEO Terry Duffy warned in an interview. This ambiguity stems from the periodic funding payments exchanged between long and short positions in perpetual contracts, which Duffy believes should legally be classified as swaps due to these recurring payments. However, if perpetual contracts are deemed futures, many institutional traders may receive a blended tax treatment, while a classification as swaps would result in ordinary taxation.
The IRS has not provided specific guidance on the tax treatment of perpetual futures, leaving market participants uncertain about how to report these positions. Legal experts agree that the issue is complex, with the definition of swaps being extremely broad and the economic function of perpetual futures differing from their textual structure. The outcome of the ongoing court battle between CME and the CFTC will significantly influence the tax implications of perpetual futures, but experts anticipate a lengthy and litigious process, potentially involving the Supreme Court and separate guidance from the IRS.